Alesco Advisors’s Elevance Health ELV Stock Holding History

Alesco Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,576	Closed	-$1.05M	–	242
2026 Q1	$1.05M	Buy	+3,576	New	+$1.18M	0.03%	108

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Alesco Advisors's ELV Position: Q2 2026 in Review

Alesco Advisors sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 3,576 shares — an estimated $1.05M sold.

Alesco Advisors first reported a position in ELV in Q1 2026 and held it in 1 quarter. The position peaked at $1.05M in Q1 2026. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Alesco Advisors reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Alesco Advisors sold 3,576 Elevance Health shares in Q2 2026, an estimated $1.05M.
Alesco Advisors first reported a position in Elevance Health in Q1 2026 and held it in 1 quarter.
Alesco Advisors's Elevance Health position peaked at $1.05M in Q1 2026.
917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Alesco Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.